
FDA Draft Guidance on Real-World Evidence: Specific Aspects
The article highlights the key points related to the specific aspects to be considered when using real-world data to support marketing applications related to medical devices.
The article highlights the key points related to the specific aspects to be considered when using real-world data to support marketing applications related to medical devices.
The new article highlights the aspects related to the current version of the electronic submission template and outlines the key points to be considered by submitters (applicants).
The new article describes in detail the aspects related to different types of MRI safety labelling to be used to indicate the safety status of the device intended to be marketed and used in the US.
The new article highlights the aspects related to the device description to be included in premarket notification submissions under the respective legal framework.
The article provides a general overview of the existing regulatory framework associated with adverse events.
The article addresses the aspects related to the existing legal framework associated with AST system devices and highlights the key points to be considered. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in...